Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors inside the central anxious technique, conolidine modulates alternate molecular targets. A Science Advances review uncovered that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availabi... https://jakel158wjg0.wizzardsblog.com/profile